152 related articles for article (PubMed ID: 29736936)
1. HLA and MuSK-positive myasthenia gravis: A systemic review and meta-analysis.
Hong Y; Li HF; Romi F; Skeie GO; Gilhus NE
Acta Neurol Scand; 2018 Sep; 138(3):219-226. PubMed ID: 29736936
[TBL] [Abstract][Full Text] [Related]
2. Association of HLA-DRB1∗14, -DRB1∗16 and -DQB1∗05 with MuSK-myasthenia gravis in patients from Turkey.
Alahgholi-Hajibehzad M; Yilmaz V; Gülsen-Parman Y; Aysal F; Oflazer P; Deymeer F; Saruhan-Direskeneli G
Hum Immunol; 2013 Dec; 74(12):1633-5. PubMed ID: 23993985
[TBL] [Abstract][Full Text] [Related]
3. High frequency of DQB1*05 and absolute absence of DRB1*13 in muscle-specific tyrosine kinase positive myasthenia gravis.
Nikolic AV; Andric ZP; Simonovic RB; Rakocevic Stojanovic VM; Basta IZ; Bojic SD; Lavrnic DV
Eur J Neurol; 2015 Jan; 22(1):59-63. PubMed ID: 25070808
[TBL] [Abstract][Full Text] [Related]
4. Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5.
Niks EH; Kuks JB; Roep BO; Haasnoot GW; Verduijn W; Ballieux BE; De Baets MH; Vincent A; Verschuuren JJ
Neurology; 2006 Jun; 66(11):1772-4. PubMed ID: 16769963
[TBL] [Abstract][Full Text] [Related]
5. Relation of HLA-DRB1 to IgG4 autoantibody and cytokine production in muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG).
Çebi M; Durmuş H; Yılmaz V; Yentür SP; Aysal F; Oflazer P; Parman Y; Deymeer F; Saruhan-Direskeneli G
Clin Exp Immunol; 2019 Aug; 197(2):214-221. PubMed ID: 30929252
[TBL] [Abstract][Full Text] [Related]
6. HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5.
Bartoccioni E; Scuderi F; Augugliaro A; Chiatamone Ranieri S; Sauchelli D; Alboino P; Marino M; Evoli A
Neurology; 2009 Jan; 72(2):195-7. PubMed ID: 19139372
[No Abstract] [Full Text] [Related]
7. HLA-DRB1*14 and DQB1*05 are associated with Japanese anti-MuSK antibody-positive myasthenia gravis patients.
Kanai T; Uzawa A; Kawaguchi N; Sakamaki T; Yoshiyama Y; Himuro K; Oda F; Kuwabara S
J Neurol Sci; 2016 Apr; 363():116-8. PubMed ID: 27000234
[TBL] [Abstract][Full Text] [Related]
8. Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis.
Saruhan-Direskeneli G; Hughes T; Yilmaz V; Durmus H; Adler A; Alahgholi-Hajibehzad M; Aysal F; Yentür SP; Akalin MA; Dogan O; Marx A; Gülsen-Parman Y; Oflazer P; Deymeer F; Sawalha AH
Clin Immunol; 2016 May; 166-167():81-8. PubMed ID: 27181991
[TBL] [Abstract][Full Text] [Related]
9. Association of HLA class II (DRB1, DQA1, DQB1) alleles and haplotypes with myasthenia gravis and its subgroups in the Iranian population.
Ehsan S; Amirzargar A; Yekaninejad MS; Mahmoudi M; Mehravar S; Moradi B; Nafissi S
J Neurol Sci; 2015 Dec; 359(1-2):335-42. PubMed ID: 26671138
[TBL] [Abstract][Full Text] [Related]
10. T cell repertoire in DQ5-positive MuSK-positive myasthenia gravis patients.
Marino M; Maiuri MT; Di Sante G; Scuderi F; La Carpia F; Trakas N; Provenzano C; Zisimopoulou P; Ria F; Tzartos SJ; Evoli A; Bartoccioni E
J Autoimmun; 2014 Aug; 52():113-21. PubMed ID: 24397960
[TBL] [Abstract][Full Text] [Related]
11. HLA-DQA1*03:02/DQB1*03:03:02 is strongly associated with susceptibility to childhood-onset ocular myasthenia gravis in Southern Han Chinese.
Zhu WH; Lu JH; Lin J; Xi JY; Lu J; Luo SS; Qiao K; Xiao BG; Lu CZ; Zhao CB
J Neuroimmunol; 2012 Jun; 247(1-2):81-5. PubMed ID: 22503410
[TBL] [Abstract][Full Text] [Related]
12. Human Leukocyte Antigen Class II associations in late-onset Myasthenia Gravis.
Spagni G; Todi L; Monte G; Valentini M; Di Sante G; Damato V; Marino M; Evoli A; Lantieri F; Provenzano C
Ann Clin Transl Neurol; 2021 Mar; 8(3):656-665. PubMed ID: 33547763
[TBL] [Abstract][Full Text] [Related]
13. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
Caress JB; Hunt CH; Batish SD
Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
[TBL] [Abstract][Full Text] [Related]
14. The association of specific HLA class I and II alleles with type 1 diabetes among Filipinos.
Bugawan TL; Klitz W; Alejandrino M; Ching J; Panelo A; Solfelix CM; Petrone A; Buzzetti R; Pozzilli P; Erlich HA
Tissue Antigens; 2002 Jun; 59(6):452-69. PubMed ID: 12445315
[TBL] [Abstract][Full Text] [Related]
15. Muscle-Specific Kinase Myasthenia Gravis.
Borges LS; Richman DP
Front Immunol; 2020; 11():707. PubMed ID: 32457737
[TBL] [Abstract][Full Text] [Related]
16. Familial autoimmune MuSK positive myasthenia gravis.
Corda D; Deiana GA; Mulargia M; Pirastru MI; Serra M; Piluzza MG; Carcassi C; Sechi G
J Neurol; 2011 Aug; 258(8):1559-60. PubMed ID: 21369718
[No Abstract] [Full Text] [Related]
17. The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.
Koneczny I; Cossins J; Vincent A
J Anat; 2014 Jan; 224(1):29-35. PubMed ID: 23458718
[TBL] [Abstract][Full Text] [Related]
18. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
[TBL] [Abstract][Full Text] [Related]
19. Dysautonomia as the Presenting Symptom in Anti-Muscle-Specific Kinase Antibody Myasthenia Gravis.
Bekooij TJS; Gilhuis HJ; Dawson L; Niks EH
J Neuromuscul Dis; 2020; 7(1):47-50. PubMed ID: 31868676
[TBL] [Abstract][Full Text] [Related]
20. HLA-DQB1*05:02, *05:03, and *03:01 alleles as risk factors for myasthenia gravis in a Spanish cohort.
Salvado M; Caro JL; Garcia C; Rudilla F; Zalba-Jadraque L; Lopez E; Sanjuan E; Gamez J; Vidal-Taboada JM
Neurol Sci; 2022 Aug; 43(8):5057-5065. PubMed ID: 35524016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
